Home>>Signaling Pathways>> Others>> Adenylate cyclase>>N6-methyladenosine (m6A)

N6-methyladenosine (m6A) Sale

(Synonyms: N6-甲基腺苷; 6-Methyladenosine; N-Methyladenosine) 目录号 : GC14698

N6-methyladenosine (m6A)是腺苷的潜在激动剂,ED50值为17250nM。

N6-methyladenosine (m6A) Chemical Structure

Cas No.:1867-73-8

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥368.00
现货
100mg
¥630.00
现货
500mg
¥1,071.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

N6-methyladenosine (m6A) is a potential agonist of adenosine with an ED50 value of 17250nM[1]. N6-methyladenosine is the methylation occurring at the N6 position of adenine, and is the most common internal modification on eukaryotic mRNA[2]. N6-methyladenosine regulates gene expression, thereby controlling a series of processes such as cell self-renewal, differentiation, invasion and apoptosis[3]. A global decrease in N6-methyladenosine (m6A) results in double-stranded RNA (dsRNA) formation and a profound cell-intrinsic interferon response[4]. The changes in N6-methyladenosine levels are closely related to the clinical and pathological features of gastrointestinal tumors and liver cancer. N6-methyladenosine has become a potential diagnostic and prognostic marker or a promising therapeutic target[5].

References:
[1] Ribeiro J A, Sebastião A M. On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction[J]. British journal of pharmacology, 1985, 84(4): 911.
[2] Chen M, Wong C M. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis[J]. Molecular cancer, 2020, 19(1): 44.
[3] He L, Li H, Wu A, et al. Functions of N6-methyladenosine and its role in cancer[J]. Molecular cancer, 2019, 18(1): 176.
[4] Guirguis A A, Ofir-Rosenfeld Y, Knezevic K, et al. Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity[J]. Cancer Discovery, 2023, 13(10): 2228-2247.
[5] Zhu D H, Su K K, Ou-Yang X X, et al. Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers[J]. Molecular and Cellular Biochemistry, 2024, 479(7): 1553-1570.

N6-methyladenosine (m6A)是腺苷的潜在激动剂,ED50值为17250nM[1]。作为腺嘌呤N6位点的甲基化修饰,N6-methyladenosine是真核生物mRNA中最常见的内源性化学修饰[2]。N6-methyladenosine通过调控基因表达,参与细胞自我更新、分化、侵袭和凋亡等一系列生物学过程[3]。整体性N6-methyladenosine水平降低会导致双链RNA(dsRNA)形成并引发强烈的细胞内在干扰素反应[4]。N6-methyladenosine水平变化与胃肠道肿瘤和肝癌的临床病理特征密切相关,已成为潜在的诊断预后标志物和治疗靶点[5]

化学性质

Cas No. 1867-73-8 SDF
别名 N6-甲基腺苷; 6-Methyladenosine; N-Methyladenosine
化学名 (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
Canonical SMILES CNC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])CO)C2=NC=N1
分子式 C11H15N5O4 分子量 281.27
溶解度 ≥ 12.2mg/mL in DMSO 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.5553 mL 17.7765 mL 35.553 mL
5 mM 711.1 μL 3.5553 mL 7.1106 mL
10 mM 355.5 μL 1.7777 mL 3.5553 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: